Algeria Achieves 83% Pharmaceutical Self-Sufficiency, Aims for Full Coverage

The Algerian pharmaceutical sector presents opportunities for investors focused on local manufacturing and technology transfer. Companies specializing in pharmaceutical equipment, raw materials, and research and development could benefit from partnerships with Algerian firms. Investors should closely monitor regulatory changes and government incentives to capitalize on the growing domestic market.